BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25047329)

  • 1. Preparation and preliminary evaluation of 63Zn-zinc citrate as a novel PET imaging biomarker for zinc.
    DeGrado TR; Pandey MK; Byrne JF; Engelbrecht HP; Jiang H; Packard AB; Thomas KA; Jacobson MS; Curran GL; Lowe VJ
    J Nucl Med; 2014 Aug; 55(8):1348-54. PubMed ID: 25047329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First PET Imaging Studies With 63Zn-Zinc Citrate in Healthy Human Participants and Patients With Alzheimer Disease.
    DeGrado TR; Kemp BJ; Pandey MK; Jiang H; Gunderson TM; Linscheid LR; Woodwick AR; McConnell DM; Fletcher JG; Johnson GB; Petersen RC; Knopman DS; Lowe VJ
    Mol Imaging; 2016; 15():. PubMed ID: 27941122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging zinc trafficking in vivo by positron emission tomography with zinc-62.
    Firth G; Yu Z; Bartnicka JJ; Parker D; Kim J; Sunassee K; Greenwood HE; Al-Salamee F; Jauregui-Osoro M; Di Pietro A; Guzman J; Blower PJ
    Metallomics; 2022 Oct; 14(10):. PubMed ID: 36201445
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Nelson BJB; Leier S; Wilson J; Wuest M; Doupe J; Andersson JD; Wuest F
    Nucl Med Biol; 2024; 128-129():108875. PubMed ID: 38199184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective production of ⁶⁵Zn with a PET cyclotron.
    Lucconi G; Cicoria G; Pancaldi D; Malizia C; Marengo M
    Appl Radiat Isot; 2012 Aug; 70(8):1590-4. PubMed ID: 22732395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclotron production of (68)Ga via the (68)Zn(p,n)(68)Ga reaction in aqueous solution.
    Pandey MK; Byrne JF; Jiang H; Packard AB; DeGrado TR
    Am J Nucl Med Mol Imaging; 2014; 4(4):303-10. PubMed ID: 24982816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taking cyclotron
    Nelson BJB; Wilson J; Richter S; Duke MJM; Wuest M; Wuest F
    Nucl Med Biol; 2020; 80-81():24-31. PubMed ID: 32004935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved 62Zn/62Cu generator based on a cation exchanger and its fully remote-controlled preparation for clinical use.
    Fukumura T; Okada K; Suzuki H; Nakao R; Mukai K; Szelecsényi F; Kovács Z; Suzuki K
    Nucl Med Biol; 2006 Aug; 33(6):821-7. PubMed ID: 16934701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new zinc-62/copper-62 generator as a copper-62 source for PET radiopharmaceuticals.
    Fujibayashi Y; Matsumoto K; Yonekura Y; Konishi J; Yokoyama A
    J Nucl Med; 1989 Nov; 30(11):1838-42. PubMed ID: 2809748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a new separation method to produce qualitatively improved
    van der Meulen NP; Hasler R; Blanc A; Farkas R; Benešová M; Talip Z; Müller C; Schibli R
    J Labelled Comp Radiopharm; 2019 Jun; 62(8):460-470. PubMed ID: 30916408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion-exchange of Pb2+, Cu2+, Zn2+, Cd2+, and Ni2+ ions from aqueous solution by Lewatit CNP 80.
    Pehlivan E; Altun T
    J Hazard Mater; 2007 Feb; 140(1-2):299-307. PubMed ID: 17045738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of a radiolabeled bis-zinc(II)-cyclen complex as a potential probe for in vivo imaging of cell death.
    Wang H; Wu Z; Li S; Hu K; Tang G
    Apoptosis; 2017 Apr; 22(4):585-595. PubMed ID: 28084570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of [(61)Cu]-thiophene-2-aldehyde thiosemicarbazone for PET studies.
    Jalilian AR; Nikzad M; Zandi H; Kharat AN; Rowshanfarzad P; Akhlaghi M; Bolourinovin F
    Nucl Med Rev Cent East Eur; 2008; 11(2):41-7. PubMed ID: 19585453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing Reliable Cu-64 Production Process: From Target Plating to Molecular Specific Tumor Micro-PET Imaging.
    Xie Q; Zhu H; Wang F; Meng X; Ren Q; Xia C; Yang Z
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28420176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging.
    Persson M; El Ali HH; Binderup T; Pfeifer A; Madsen J; Rasmussen P; Kjaer A
    Nucl Med Biol; 2014 Mar; 41(3):290-5. PubMed ID: 24533988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor.
    Li F; Jiang S; Zu Y; Lee DY; Li Z
    J Nucl Med; 2014 Sep; 55(9):1525-31. PubMed ID: 24970912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclotron production of
    Pandey MK; Byrne JF; Schlasner KN; Schmit NR; DeGrado TR
    Nucl Med Biol; 2019; 74-75():49-55. PubMed ID: 31085059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM.
    Haynes NG; Lacy JL; Nayak N; Martin CS; Dai D; Mathias CJ; Green MA
    J Nucl Med; 2000 Feb; 41(2):309-14. PubMed ID: 10688116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of [61Cu]-2-acetylpyridine thiosemicarbazone complex as a possible PET tracer for malignancies.
    Jalilian AR; Rowshanfarzad P; Sabet M; Shafiee A
    Appl Radiat Isot; 2006 Mar; 64(3):337-41. PubMed ID: 16293418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
    Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
    J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.